Cargando…
Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275775/ https://www.ncbi.nlm.nih.gov/pubmed/18210105 http://dx.doi.org/10.1007/s00259-008-0722-4 |
| _version_ | 1782151904294338560 |
|---|---|
| author | Bax, Jeroen J. Boogers, Mark Henneman, Maureen M. |
| author_facet | Bax, Jeroen J. Boogers, Mark Henneman, Maureen M. |
| author_sort | Bax, Jeroen J. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2275775 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | Springer-Verlag |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-22757752008-03-28 Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? Bax, Jeroen J. Boogers, Mark Henneman, Maureen M. Eur J Nucl Med Mol Imaging Editorial Commentary Springer-Verlag 2008-01-22 2008 /pmc/articles/PMC2275775/ /pubmed/18210105 http://dx.doi.org/10.1007/s00259-008-0722-4 Text en © The Author(s) 2008 https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Editorial Commentary Bax, Jeroen J. Boogers, Mark Henneman, Maureen M. Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? |
| title | Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? |
| title_full | Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? |
| title_fullStr | Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? |
| title_full_unstemmed | Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? |
| title_short | Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? |
| title_sort | can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275775/ https://www.ncbi.nlm.nih.gov/pubmed/18210105 http://dx.doi.org/10.1007/s00259-008-0722-4 |
| work_keys_str_mv | AT baxjeroenj cancardiaciodine123metaiodobenzylguanidineimagingcontributetoriskstratificationinheartfailurepatients AT boogersmark cancardiaciodine123metaiodobenzylguanidineimagingcontributetoriskstratificationinheartfailurepatients AT hennemanmaureenm cancardiaciodine123metaiodobenzylguanidineimagingcontributetoriskstratificationinheartfailurepatients |